A D.C. drugmaker is fighting the FDA on multiple fronts, from trying protect its intellectual property from generic ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

Donald Trump’s more controversial personnel choices have prompted fears that Tulsi Gabbard would compromise intelligence ...

First recommended by a Trump-appointed FDA leader, multiple administrations have collaborated to snuff out this issue that ...